CAS No. |
1256639-86-7 |
中文名称 |
(8S,10S)-8-乙酰基-10-(((2R,4S,5S,6S)-4-氨基-5-羟基-6-甲基四氢-2H-吡喃-2-基)氧基)-6,8,11-三羟基-1-甲氧基-7,8,9,10-四氢四并苯-5,12-二酮--4-氨基-1-((2R,3S,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮(1/1) |
英文名称 |
(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione--4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one (1/1) |
别名 |
CPX 351;CPX351;CPX-351;Cytarabine/daunonubicin;Daunonubicin/cytarabine;Vyxeos;5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-, mixt. with 4-amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone |
标准英文名 |
(8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione--4-amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one (1/1) |
分子式 |
C36H42N4O15 |
分子量 |
770.74
|
精确分子量 |
770.26
|
SMILES |
COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(O)=C1C2=O.NC1=NC(=O)N([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C=C1 |
标准SMILES |
CC(=O)[C@]1(O)CC2=C([C@H](C1)O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1)C(O)=C1C(C(=O)C3C=CC=C(OC)C=3C1=O)=C2O.NC1C=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)N=1 |
InChIKey |
HBQCEICSYDCGJG-SZXLQUARSA-N |